Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6548705 | 0.82 | CA2 (0.37) | — | |
| SCHEMBL6549485 | 0.81 | CA2 (0.36) | — | |
| SCHEMBL6551473 | 0.81 | CXCR2 (0.30) | CXCR2 | |
| SCHEMBL6550463 | 0.81 | CXCR2 (0.30) | CXCR2 | |
| SCHEMBL6551443 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL6736327 | 0.76 | HSD11B1 (0.40) | — | |
| SCHEMBL6549850 | 0.76 | HSD11B1 (0.37) | — | |
| SCHEMBL6549745 | 0.74 | CES1 (0.36) | — | |
| SCHEMBL6548747 | 0.74 | FFAR3 (0.31) | — | |
| SCHEMBL6550735 | 0.71 | FAAH (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1167349-B1 | Chemical amplifying type positive resist composition | SUMITOMO CHEMICAL CO (JP) | 2004-12-01 | — | — | EP | disclosed |
| US-20040224251-A1 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6548220-B2 | Containing acid generator | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20020015913-A1 | Chemical amplifying type positive resist composition and sulfonium salt | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-07 | — | — | US | disclosed |
| EP-1167349-A1 | Chemical amplifying type positive resist composition and sulfonium salt | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-02 | — | — | EP | disclosed |